Bergmann Glial S100B Activates Myo-inositol Monophosphatase 1 and Co-localizes to Purkinje Cell Vacuoles in SCA1 Transgenic Mice

被引:37
|
作者
Vig, Parminder J. S. [1 ]
Shao, Qingmei [1 ]
Subramony, S. H. [1 ]
Lopez, Mariper E. [1 ]
Safaya, Eshan [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA
关键词
Purkinje cells; S100B; Myo-inositol monophosphatase 1; Spinocerebellar ataxia-1; Cerebellum; Vacuoles; Neurodegeneration; Glia; FIBRILLARY ACIDIC PROTEIN; CALCIUM-BINDING PROTEINS; MESSENGER-RNA; VIMENTIN; IMMUNOREACTIVITY; EXPRESSION; NEURONS; ATAXIA; NEURODEGENERATION; CALBINDIN-D28K;
D O I
10.1007/s12311-009-0125-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinocerebellar ataxia-1 (SCA1) is a late onset neurodegenerative disease caused by the expansion of a polyglutamine repeat within ataxin-1 protein. The toxic effects triggered by mutant ataxin-1 result in degeneration of the neurons in cerebellum, brain stem and spinocerebellar tracts. The targeted overexpression of mutant ataxin-1 in cerebellar Purkinje cells (PCs) of the SCA1 transgenic mice results in the formation of cytoplasmic vacuoles in PCs. These vacuoles appear early on before the onset of behavioral abnormalities. Interestingly, we found that vacoules contain S100B and vimentin proteins, which normally localize to neighboring Bergmann glia (BG). Further, immunohistochemical and specialized silver stain analysis revealed that vacuolar formation is associated with alterations in the morphology of dendritic spines of PCs. To gain insights into the mechanisms of vacuolar formation, we investigated if vacuoles in SCA1 PCs have an autophagic origin or are a consequence of some other event. We examined the expression levels (by Western blotting) of microtubule-associated protein light chain 3 (LC3)-I and LC3-II, and the degradation levels of p62 (a LC3 partner) in the cerebellar fractions prepared from pre-symptomatic SCA1 and age-matched wild-type mice. No p62 degradation was observed; however, LC3-II/(LC3-I + LC3-II) ratios were significantly altered in SCA1 mice indicating changes in the autophagic flux. In addition, LC3 localized to PC vacuoles. Further, we observed a co-localization of myo-inositol monophosphatase 1 (IMPA1) with S100B in PC vacuoles. IMPA1 is present in PC spines and has been implicated in autophagy. In vitro studies using purified IMPA1 and S100B demonstrated that S100B interacted with and activated IMPA1. Both apo and Ca2+-bound S100B were found to activate IMPA1, depending on substrate concentration. IMPA1 is regulated by another calcium-binding protein calbindin-D28k (CaB), since we reported earlier that the CaB levels are reduced in SCA1 PCs, the activation of IMPA1 by S100B may modulate CaB-dependent inositol signaling. This may cause BG-PC interface to degenerate resulting in vacuolar formation. In sum, these data indicate that vacuoles appearing early in SCA1 PCs could be developing through some unknown autophagic mechanism.
引用
收藏
页码:231 / 244
页数:14
相关论文
共 4 条
  • [1] Bergmann Glial S100B Activates Myo-inositol Monophosphatase 1 and Co-localizes to Purkinje Cell Vacuoles in SCA1 Transgenic Mice
    Parminder J. S. Vig
    Qingmei Shao
    S. H. Subramony
    Mariper E. Lopez
    Eshan Safaya
    The Cerebellum, 2009, 8 : 231 - 244
  • [2] Glial S100B Protein Modulates Mutant Ataxin-1 Aggregation and Toxicity: TRTK12 Peptide, a Potential Candidate for SCA1 Therapy
    Parminder J. S. Vig
    Scoty Hearst
    Qingmei Shao
    Mariper E. Lopez
    Henry A. Murphy
    Eshan Safaya
    The Cerebellum, 2011, 10 : 254 - 266
  • [3] Glial S100B Protein Modulates Mutant Ataxin-1 Aggregation and Toxicity: TRTK12 Peptide, a Potential Candidate for SCA1 Therapy
    Vig, Parminder J. S.
    Hearst, Scoty
    Shao, Qingmei
    Lopez, Mariper E.
    Murphy, Henry A., II
    Safaya, Eshan
    CEREBELLUM, 2011, 10 (02) : 254 - 266
  • [4] Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol
    Rothermundt, Matthias
    Ohrmann, Patricia
    Abel, Simone
    Siegmund, Ansgar
    Pedersen, Anya
    Ponath, Gerald
    Suslow, Thomas
    Peters, Marion
    Kaestner, Florian
    Heindel, Walter
    Arolt, Volker
    Pfleiderer, Bettina
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (02) : 361 - 364